TCR2 THERAPEUTICS INC's ticker is TCRR and the CUSIP is 87808K106.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $361,900 | +218.2% | 241,266 | +111.9% | 0.00% | – |
| Q4 2022 | $113,724 | -38.5% | 113,861 | +10.6% | 0.00% | – |
| Q3 2022 | $185,000 | -38.3% | 102,921 | -0.4% | 0.00% | – |
| Q2 2022 | $300,000 | +4.9% | 103,354 | -0.3% | 0.00% | – |
| Q1 2022 | $286,000 | +28500.0% | 103,698 | +37608.4% | 0.00% | – |
| Q4 2021 | $1,000 | -99.9% | 275 | -99.9% | 0.00% | – |
| Q3 2021 | $1,886,000 | -72.9% | 221,635 | -47.8% | 0.00% | -100.0% |
| Q2 2021 | $6,971,000 | -31.2% | 424,800 | -7.4% | 0.00% | 0.0% |
| Q1 2021 | $10,128,000 | -28.6% | 458,700 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $14,188,000 | +77.9% | 458,700 | +16.9% | 0.00% | 0.0% |
| Q3 2020 | $7,976,000 | +797500.0% | 392,500 | +503105.1% | 0.00% | – |
| Q3 2019 | $1,000 | – | 78 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 3,370,982 | $68,498,000 | 16.50% |
| MPM ASSET MANAGEMENT LLC | 4,050,865 | $82,314,000 | 15.35% |
| Consonance Capital Management LP | 1,509,819 | $30,680,000 | 3.74% |
| Soleus Capital Management, L.P. | 282,041 | $5,731,000 | 3.04% |
| Redmile Group, LLC | 2,793,288 | $56,760,000 | 1.04% |
| PFM Health Sciences, LP | 775,794 | $15,764,000 | 0.73% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,200,000 | $24,384,000 | 0.59% |
| Cormorant Asset Management, LP | 600,000 | $12,192,000 | 0.47% |
| Sofinnova Investments, Inc. | 173,028 | $3,516,000 | 0.26% |
| Artal Group S.A. | 500,000 | $10,160,000 | 0.25% |